Breast Cancer Clinical Trial

Cone Beam Breast CT for Breast Cancer Screening

Summary

Up to one thousand and twenty-eight (1028) patients from screening and diagnostic population will be enrolled and consented to participate in the study to create an enriched data set. These women will be enrolled from annual screening population and diagnostic workup population. The enrolled patient will undergo KBCT scans within 4 weeks of her screening or diagnostic mammography exam and before breast biopsy occurs if biopsy is needed.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Screening Group:

Female sex of any ethnicity
Age 40 years or older
Scheduled for a routine screening mammography exam within 4 weeks.

Diagnostic Group:

Female sex of any ethnicity
Age 20 years or older
Have an abnormality detected by Breast Self Exam (BSE), or Clinical Breast Exam (CBE), or have an abnormality detected by an imaging modality.
Will undergo diagnostic mammography, prior to breast biopsy (if needed).

Exclusion Criteria:

Pregnancy
Lactation

Unknown pregnancy status AND

has refused pregnancy testing and
has refused to sign a pregnancy test waiver
Women who are unable or unwilling to understand or to provide informed consent
Women with physical limitations that may prohibit resting prone on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pace maker.
Women who are unable to tolerate study constraints.

Women who have received radiation treatments to the thorax or breast area for malignant and nonmalignant conditions, such as (but not limited to):

Treatment for enlarged thymus gland as an infant
Irradiation for benign breast conditions, including breast inflammation after giving birth
Treatment for Hodgkin's disease
Women who have participated in a prior breast clinical trial that gave additional radiation dose, such as an additional mammogram.

Women who have received large numbers of diagnostic x-ray examinations for monitoring of disease such as (but not limited to):

Tuberculosis
Severe scoliosis Additional exclusion criteria due to machine limitations
Patient's body weight is over the limit of the scanner table (440 lbs. or 200kg)

Study is for people with:

Breast Cancer

Estimated Enrollment:

1024

Study ID:

NCT05036096

Recruitment Status:

Recruiting

Sponsor:

Koning Corporation

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Port Orange Imaging Center
Port Orange Florida, 32129, United States More Info
John Carroll, MD
Contact
386-322-1616
[email protected]
John Carroll, MD
Principal Investigator
Knoxville Comprehensive Breast Center
Knoxville Tennessee, 37909, United States More Info
Kamilia Frances Kozlowski, M.D.
Contact
(865) 584-0291
[email protected]
Nancy Ortiz
Contact
(865) 583-1002
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

1024

Study ID:

NCT05036096

Recruitment Status:

Recruiting

Sponsor:


Koning Corporation

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider